NCT04529616View on ClinicalTrials.gov

Single Center Exploratory Study To Evaluate The Use Of The RxSight Light Adjustable Lens (LAL) And The Light Delivery Device (LDD) To Improve Visual Outcomes

CompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

May 22, 2020

Primary Completion Date

October 1, 2022

Study Completion Date

October 1, 2022

Conditions
AphakiaCataract
Interventions
DEVICE

Light Adjustable lens (LAL) and Light Delivery Device (LDD)

Eligible eyes will receive Light adjustable lens with Light delivery Device treatments

Trial Locations (1)

Unknown

CODET Vision Institute, Tijuana

All Listed Sponsors
lead

RxSight, Inc.

INDUSTRY

NCT04529616 - Single Center Exploratory Study To Evaluate The Use Of The RxSight Light Adjustable Lens (LAL) And The Light Delivery Device (LDD) To Improve Visual Outcomes | Biotech Hunter | Biotech Hunter